PS, Y., CL, C., CP, H., YH, L., & KH, T. (2018). An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin. Dove Medical Press.
Cita Chicago Style (17a ed.)PS, Yang, Chen CL, Hou CP, Lin YH, y Tsui KH. An Open-label, Prospective Interventional Study of the Tolerability and Efficacy of 0.4 Mg Oral Tamsulosin Oral Controlled Absorption System in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia Who Are Unsatisfied with Treatment with 0.2 Mg Tamsulosin. Dove Medical Press, 2018.
Cita MLA (8a ed.)PS, Yang, et al. An Open-label, Prospective Interventional Study of the Tolerability and Efficacy of 0.4 Mg Oral Tamsulosin Oral Controlled Absorption System in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia Who Are Unsatisfied with Treatment with 0.2 Mg Tamsulosin. Dove Medical Press, 2018.